Showing results (81-90 of 105) with videos related to

Sort By:
Pageof 11
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
MMAF for advanced gastric cancerH Anderson, J H Scarffe, M Ranson, et al.
British Journal of Haematology|September 6, 2000
Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoietic progenitor rescueA M Wardley, G C Jayson, R Swindell, et al.
Cancer Treatment Reports|November 1, 1985
Phase II trial of epirubicin in gastric cancerJ H Scarffe, J B Kenny, R J Johnson, et al.
British Journal of Cancer|December 1, 1987
Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancerM H Bronchud, J H Scarffe, N Thatcher, et al.
International Journal of Cancer|November 15, 1994
Haemopoietic progenitor and myeloid cell kinetics in humans treated with interleukin-3 and granulocyte/macrophage colony-stimulating factor in combinationB I Lord, N G Testa, S Bretti, et al.
Bone Marrow Transplantation|January 1, 1989
The use of bone marrow cells grown in long-term culture for autologous bone marrow transplantation in acute myeloid leukaemia: an updateJ Chang, G R Morgenstern, L H Coutinho, et al.
Hematological Oncology|July 1, 1987
VAD chemotherapy--toxicity and efficacy--in patients with multiple myeloma and other lymphoid malignanciesH Anderson, J H Scarffe, M Lambert, et al.
British Journal of Cancer|May 14, 1998
Recombinant human granulocyte colony-stimulating factor (filgrastim) following high-dose chemotherapy and peripheral blood progenitor cell rescue in high-grade non-Hodgkin's lymphoma: clinical benefits at no extra costS M Lee, J A Radford, L Dobson, et al.
Cancer Treatment Reports|April 1, 1986
Alpha-2-interferon/melphalan/prednisone in previously untreated patients with multiple myeloma: a phase I-II trialM R Cooper, A Fefer, J Thompson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1985
Phase II study of recombinant alpha-2 interferon in resistant multiple myelomaJ J Costanzi, M R Cooper, J H Scarffe, et al.
Pageof 11